Skip to main content
    L

    LivaNova PLC (LIVN)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $91.92
    -0.52 (-0.56%)

    Market Cap: $5.03B

    Last updated: Nov 17, 2026 at 4:20 PM ET

    LivaNova PLC (LIVN) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    LivaNova (LIVN) has a market cap of $5.03B and an enterprise value of $4.77B. Its share count is up 3.99% from a year earlier. Its return on invested capital of 9.74% compares with a 4.94% median across 8 similar companies.

    Total Valuation

    Enterprise value is 5.26% below the market cap, as cash exceeds debt.

    Market Cap$5.03B
    Enterprise Value$4.77B
    Latest price (Nov 17, 2026)$91.92

    Key Dates

    The next earnings report is expected on Feb 23, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 23, 2027 (expected)
    Last Earnings DateNov 4, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 1.95% in the quarter ended Sep 30, 2026 and grew 2.55% a year over 2 years.

    Shares Outstanding57.40M
    Shares Change (YoY)+3.99%
    Shares Change (QoQ)+1.95%
    Share Count Growth (2Y CAGR)+2.55%

    Valuation Ratios

    Sales and book value multiples are 3.5x and 3.8x. Its year-end P/E ranged from 13.7x to 52.1x from 2016 to 2025.

    P/E Ratio23.6x
    Forward P/E20.3x
    P/S Ratio3.5x
    Forward P/S3.3x
    P/B Ratio3.8x
    P/TBV Ratio13.8x
    P/FCF Ratio40.9x
    P/OCF Ratio21.2x
    PEG Ratio1.3

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 23.7x EBITDA and 38.9x free cash flow.

    EV / Earnings24.3x
    EV / Sales3.2x
    EV / EBITDA23.7x
    EV / EBIT29.3x
    EV / FCF38.9x

    Price Statistics

    The stock is up 66.04% over 52 weeks and trades 13.82% above its 50-day average.

    Beta (1Y)1.03
    52-Week Change+66.04%
    1-Month Change+17.64%
    3-Month Change+13.71%
    6-Month Change+26.06%
    5-Year Change+2.93%
    10-Year Change+39.33%
    Total Return (1Y)+66.04%
    Total Return (3Y CAGR)+25.25%
    Total Return (5Y CAGR)+1.80%
    Return vs SPY (1Y)+59.01%
    Max Drawdown (1Y)-18.89%
    Max Drawdown (3Y)-47.23%
    Sharpe Ratio (1Y)1.42
    Correlation with SPY (1Y)0.37
    50-Day Average$80.76
    200-Day Average$74.44
    52-Week Range$53.37 to $99.38
    RSI (14 Days)65.6
    Average Volume (20 Days)782.87K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.46x current liabilities, and total debt is 0.22x shareholder equity.

    Current Ratio1.46x
    Quick Ratio1.22x
    Debt / Equity0.22x
    Debt / EBITDA1.42x
    Debt / FCF2.32x
    Interest Coverage3.76x

    Returns and Efficiency

    Return on invested capital is 9.74% over the last 12 months, against a 5-year average of -2.36%.

    Return on Equity (ROE)14.29%
    Return on Assets (ROA)7.23%
    Return on Invested Capital (ROIC)9.74%
    Return on Capital Employed (ROCE)8.25%
    ROE (5Y Average)-6.34%
    ROA (5Y Average)-3.20%
    ROIC (5Y Average)-2.36%
    Asset Turnover0.57x
    Inventory Turnover2.76x
    Receivables Turnover5.41x
    Cash Conversion Cycle120 days

    Scores

    LIVN has an Altman Z-Score of 2.76, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.

    Altman Z-Score2.76
    Altman Z ZoneGrey
    Piotroski F-Score5 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $1.51B over the last 12 months is up 11.70% from the 12 months before.

    Revenue$1.51B
    Revenue Growth (YoY)+11.70%
    Gross Profit$1.02B
    Operating Income$172.70M
    Pretax Income$119.59M
    Net Income$196.08M
    EBITDA$211.36M
    EBIT$162.79M
    Reported EPS (TTM)$3.89

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 50.55% of the $2.71B in total assets.

    Cash and Equivalents$563.50M
    Total Debt$299.09M
    Net Cash$264.41M
    Net Cash Per Share$4.61
    Working Capital$342.60M
    Shareholder Equity$1.37B
    Book Value Per Share$23.90
    Tangible Book Value$382.60M
    Tangible Book Per Share$6.67
    Total Assets$2.71B
    Total Liabilities$1.34B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $108.84M of capital spending, operating cash flow left $128.96M of free cash flow.

    Operating Cash Flow$237.80M
    Capital Expenditures$108.84M
    Free Cash Flow$128.96M
    FCF Per Share$2.34
    Depreciation and Amortization$64.00M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 11.46%, against a 5-year average of 2.23%.

    Gross Margin67.91%
    Operating Margin11.46%
    Pretax Margin7.94%
    Net Margin13.01%
    EBITDA Margin14.03%
    EBIT Margin10.80%
    FCF Margin8.56%
    Gross Margin (5Y Average)68.29%
    Operating Margin (5Y Average)2.23%
    Net Margin (5Y Average)-6.49%

    Growth

    Revenue grew 10.75% a year over 3 years, and EPS 16.14% a year.

    Revenue Growth (3Y CAGR)+10.75%
    Revenue Growth (5Y CAGR)+8.24%
    EPS Growth (3Y CAGR)+16.14%
    EPS Growth (5Y CAGR)+24.24%
    FCF Growth (3Y CAGR)+58.62%
    Book Value Per Share Growth (2Y CAGR)-3.26%
    Tangible Book Per Share Growth (2Y CAGR)-13.05%

    Revenue and profit by year

    Dividends and Yields

    LIVN does not pay a dividend. Its free cash flow yield is 2.44%.

    Earnings Yield4.24%
    FCF Yield2.44%
    Shareholder Yield0.14%

    Peer Position

    Against 9 similar companies, LIVN has the 6th highest P/E.

    P/E Ratio23.6x vs 23.8x median
    P/S Ratio3.5x vs 3.5x median
    ROIC9.74% vs 4.94% median
    Revenue Growth (Trailing 4 Quarters, YoY)+11.70% vs +8.73% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 8.67% and EPS growth at 12.16% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+8.67%
    EPS Growth Forecast (2Y CAGR)+12.16%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About LIVN

    What is LIVN's market cap?

    LivaNova has a market cap of $5.03B. Its enterprise value, which adds debt and subtracts cash, is $4.77B.

    What is LIVN's P/E ratio?

    LivaNova has a trailing P/E ratio of 23.6x and a forward P/E of 20.3x.

    How many shares of LIVN are outstanding?

    LivaNova has 57.40M shares outstanding. The count is up 3.99% from a year earlier.

    Does LIVN pay a dividend?

    No. LivaNova does not pay a dividend.

    How much debt does LIVN have?

    LivaNova has $299.09M of total debt and $563.50M of cash and equivalents, a net cash position of $264.41M.